[
  {
    "ts": null,
    "headline": "1 No-Brainer Dividend Stock to Buy Now and Hold Forever",
    "summary": "Medtronic's long-term dividend streak also points to a business capable of performing well over long periods.  Healthcare giant Medtronic (NYSE: MDT) fits that description to a T. Though some might describe the company's business as \"boring,\" the medical device specialist is an excellent pick for long-term, income-seeking investors.  The past five years have been challenging for Medtronic, even beyond the business disruptions caused by the pandemic.",
    "url": "https://finnhub.io/api/news?id=d04930d6a5eca53f380390afdd65023c305dd37cec0376f2425c16f42df581be",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752049860,
      "headline": "1 No-Brainer Dividend Stock to Buy Now and Hold Forever",
      "id": 135836047,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic's long-term dividend streak also points to a business capable of performing well over long periods.  Healthcare giant Medtronic (NYSE: MDT) fits that description to a T. Though some might describe the company's business as \"boring,\" the medical device specialist is an excellent pick for long-term, income-seeking investors.  The past five years have been challenging for Medtronic, even beyond the business disruptions caused by the pandemic.",
      "url": "https://finnhub.io/api/news?id=d04930d6a5eca53f380390afdd65023c305dd37cec0376f2425c16f42df581be"
    }
  },
  {
    "ts": null,
    "headline": "DexCom Is Doubling Down on Its ‘Mistake.’ Why It’s Time to Buy the Stock.",
    "summary": "DexCom’s decision to pursue the Type 2 diabetes market wasn’t faulty. It was management’s execution of its strategy that caused the problem.",
    "url": "https://finnhub.io/api/news?id=30cb32a125d1f05543816093c8d6a2a7b95ffdbc271c378e4cdeaf46a6b5d88e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752039000,
      "headline": "DexCom Is Doubling Down on Its ‘Mistake.’ Why It’s Time to Buy the Stock.",
      "id": 135829816,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "DexCom’s decision to pursue the Type 2 diabetes market wasn’t faulty. It was management’s execution of its strategy that caused the problem.",
      "url": "https://finnhub.io/api/news?id=30cb32a125d1f05543816093c8d6a2a7b95ffdbc271c378e4cdeaf46a6b5d88e"
    }
  },
  {
    "ts": null,
    "headline": "Needham Keeps Hold Rating on Medtronic (MDT) Amid Spin-Off News",
    "summary": "Medtronic plc (NYSE:MDT) is one of the 11 Best Foreign Stocks to Buy According to Hedge Funds. On June 6, Needham analysts reiterated a “Hold” rating on Medtronic plc (NYSE:MDT). This decision came after the company announced its plans to spin off its Diabetes business into a separate public company. The analysts believe this split […]",
    "url": "https://finnhub.io/api/news?id=6f9a2973d1e9732261bd2a71494c9d8dda6a8b3f1838d43422ed19341e56d3ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752035673,
      "headline": "Needham Keeps Hold Rating on Medtronic (MDT) Amid Spin-Off News",
      "id": 135830014,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic plc (NYSE:MDT) is one of the 11 Best Foreign Stocks to Buy According to Hedge Funds. On June 6, Needham analysts reiterated a “Hold” rating on Medtronic plc (NYSE:MDT). This decision came after the company announced its plans to spin off its Diabetes business into a separate public company. The analysts believe this split […]",
      "url": "https://finnhub.io/api/news?id=6f9a2973d1e9732261bd2a71494c9d8dda6a8b3f1838d43422ed19341e56d3ce"
    }
  }
]